Copyright Reports & Markets. All rights reserved.

Global Pediatric Brain Tumor Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pediatric Brain Tumor Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Gliomas
      • 1.4.3 Mixed Neuronal-Glial Tumors
      • 1.4.4 Embryonal Tumors
      • 1.4.5 Choroid Plexus Papilloma/Carcinoma
      • 1.4.6 Tumors Arising From Non-Neuroepithelial Tissue
      • 1.4.7 Meningeal Tumors
    • 1.5 Market by Application
      • 1.5.1 Global Pediatric Brain Tumor Market Share by Application (2014-2025)
      • 1.5.2 Hospitals And Clinics
      • 1.5.3 Medical Research Centers
      • 1.5.4 Academic Institutes
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pediatric Brain Tumor Market Size
    • 2.2 Pediatric Brain Tumor Growth Trends by Regions
      • 2.2.1 Pediatric Brain Tumor Market Size by Regions (2014-2025)
      • 2.2.2 Pediatric Brain Tumor Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Pediatric Brain Tumor Market Size by Manufacturers
      • 3.1.1 Global Pediatric Brain Tumor Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Pediatric Brain Tumor Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Pediatric Brain Tumor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pediatric Brain Tumor Key Players Head office and Area Served
    • 3.3 Key Players Pediatric Brain Tumor Product/Solution/Service
    • 3.4 Date of Enter into Pediatric Brain Tumor Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pediatric Brain Tumor Market Size by Type (2014-2019)
    • 4.2 Global Pediatric Brain Tumor Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Pediatric Brain Tumor Market Size (2014-2019)
    • 5.2 Pediatric Brain Tumor Key Players in United States
    • 5.3 United States Pediatric Brain Tumor Market Size by Type
    • 5.4 United States Pediatric Brain Tumor Market Size by Application

    6 Europe

    • 6.1 Europe Pediatric Brain Tumor Market Size (2014-2019)
    • 6.2 Pediatric Brain Tumor Key Players in Europe
    • 6.3 Europe Pediatric Brain Tumor Market Size by Type
    • 6.4 Europe Pediatric Brain Tumor Market Size by Application

    7 China

    • 7.1 China Pediatric Brain Tumor Market Size (2014-2019)
    • 7.2 Pediatric Brain Tumor Key Players in China
    • 7.3 China Pediatric Brain Tumor Market Size by Type
    • 7.4 China Pediatric Brain Tumor Market Size by Application

    8 Japan

    • 8.1 Japan Pediatric Brain Tumor Market Size (2014-2019)
    • 8.2 Pediatric Brain Tumor Key Players in Japan
    • 8.3 Japan Pediatric Brain Tumor Market Size by Type
    • 8.4 Japan Pediatric Brain Tumor Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pediatric Brain Tumor Market Size (2014-2019)
    • 9.2 Pediatric Brain Tumor Key Players in Southeast Asia
    • 9.3 Southeast Asia Pediatric Brain Tumor Market Size by Type
    • 9.4 Southeast Asia Pediatric Brain Tumor Market Size by Application

    10 India

    • 10.1 India Pediatric Brain Tumor Market Size (2014-2019)
    • 10.2 Pediatric Brain Tumor Key Players in India
    • 10.3 India Pediatric Brain Tumor Market Size by Type
    • 10.4 India Pediatric Brain Tumor Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pediatric Brain Tumor Market Size (2014-2019)
    • 11.2 Pediatric Brain Tumor Key Players in Central & South America
    • 11.3 Central & South America Pediatric Brain Tumor Market Size by Type
    • 11.4 Central & South America Pediatric Brain Tumor Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott
      • 12.1.1 Abbott Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pediatric Brain Tumor Introduction
      • 12.1.4 Abbott Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.1.5 Abbott Recent Development
    • 12.2 AbbVie
      • 12.2.1 AbbVie Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pediatric Brain Tumor Introduction
      • 12.2.4 AbbVie Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.2.5 AbbVie Recent Development
    • 12.3 Akorn
      • 12.3.1 Akorn Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pediatric Brain Tumor Introduction
      • 12.3.4 Akorn Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.3.5 Akorn Recent Development
    • 12.4 Agios
      • 12.4.1 Agios Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pediatric Brain Tumor Introduction
      • 12.4.4 Agios Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.4.5 Agios Recent Development
    • 12.5 Baxter
      • 12.5.1 Baxter Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pediatric Brain Tumor Introduction
      • 12.5.4 Baxter Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.5.5 Baxter Recent Development
    • 12.6 Bayer
      • 12.6.1 Bayer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pediatric Brain Tumor Introduction
      • 12.6.4 Bayer Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.6.5 Bayer Recent Development
    • 12.7 Epizyme
      • 12.7.1 Epizyme Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pediatric Brain Tumor Introduction
      • 12.7.4 Epizyme Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.7.5 Epizyme Recent Development
    • 12.8 Novartis
      • 12.8.1 Novartis Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pediatric Brain Tumor Introduction
      • 12.8.4 Novartis Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.8.5 Novartis Recent Development
    • 12.9 Mylan
      • 12.9.1 Mylan Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pediatric Brain Tumor Introduction
      • 12.9.4 Mylan Revenue in Pediatric Brain Tumor Business (2014-2019)
      • 12.9.5 Mylan Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant).
      Treatment and chance of recovery (prognosis) depend on the type of tumor, its location within the brain, whether it has spread, and your child's age and general health. Because new treatments and technologies are continually being developed, several options may be available at different points in treatment.
      In 2018, the global Pediatric Brain Tumor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pediatric Brain Tumor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pediatric Brain Tumor development in United States, Europe and China.

      The key players covered in this study
      Abbott
      AbbVie
      Akorn
      Agios
      Baxter
      Bayer
      Epizyme
      Novartis
      Mylan

      Market segment by Type, the product can be split into
      Gliomas
      Mixed Neuronal-Glial Tumors
      Embryonal Tumors
      Choroid Plexus Papilloma/Carcinoma
      Tumors Arising From Non-Neuroepithelial Tissue
      Meningeal Tumors

      Market segment by Application, split into
      Hospitals And Clinics
      Medical Research Centers
      Academic Institutes

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pediatric Brain Tumor status, future forecast, growth opportunity, key market and key players.
      To present the Pediatric Brain Tumor development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pediatric Brain Tumor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now